Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments

2004 ◽  
Vol 287 (1-2) ◽  
pp. 147-158 ◽  
Author(s):  
Jennifer R. Cochran ◽  
Yong-Sung Kim ◽  
Mark J. Olsen ◽  
Rashna Bhandari ◽  
K.Dane Wittrup
2020 ◽  
Vol 11 ◽  
Author(s):  
Jan P. Bogen ◽  
Stefania C. Carrara ◽  
David Fiebig ◽  
Julius Grzeschik ◽  
Björn Hock ◽  
...  

Bispecific (BsAb) and biparatopic (BpAb) antibodies emerged as promising formats for therapeutic biologics exhibiting tailor-made functional properties. Over recent years, chicken-derived antibodies have gained traction for diagnostic and therapeutic applications due to their broad epitope coverage and convenience of library generation. Here we report the first generation of a biparatopic common light chain (cLC) chicken-derived antibody by an epitope binning-based screening approach using yeast surface display. The resulting monospecific antibodies target conformational epitopes on domain II or III of the epidermal growth factor receptor (EGFR) with lower double- or single-digit nanomolar affinities, respectively. Furthermore, the domain III targeting variant was shown to interfere with epidermal growth factor (EGF) binding. Utilizing the Knob-into-Hole technology (KiH), a biparatopic antibody with subnanomolar affinity was generated that facilitates clustering of soluble and cell-bound EGFR and displayed enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) compared to the parental antibodies. This strategy for generating cLC-based biparatopic antibodies from immunized chickens may pave the way for their further development in therapeutic settings.


2020 ◽  
Vol 40 (7) ◽  
Author(s):  
Eric C. Tom ◽  
Insha Mushtaq ◽  
Bhopal C. Mohapatra ◽  
Haitao Luan ◽  
Aaqib M. Bhat ◽  
...  

ABSTRACT Epidermal growth factor receptor (EGFR) is a prototype receptor tyrosine kinase and an oncoprotein in many solid tumors. Cell surface display of EGFR is essential for cellular responses to its ligands. While postactivation endocytic trafficking of EGFR has been well elucidated, little is known about mechanisms of basal/preactivation surface display of EGFR. Here, we identify a novel role of the endocytic regulator EHD1 and a potential EHD1 partner, RUSC2, in cell surface display of EGFR. EHD1 and RUSC2 colocalize with EGFR in vesicular/tubular structures and at the Golgi compartment. Inducible EHD1 knockdown reduced the cell surface EGFR expression with accumulation at the Golgi compartment, a phenotype rescued by exogenous EHD1. RUSC2 knockdown phenocopied the EHD1 depletion effects. EHD1 or RUSC2 depletion impaired the EGF-induced cell proliferation, demonstrating that the novel, EHD1- and RUSC2-dependent transport of unstimulated EGFR from the Golgi compartment to the cell surface that we describe is functionally important, with implications for physiologic and oncogenic roles of EGFR and targeted cancer therapies.


Sign in / Sign up

Export Citation Format

Share Document